Study S002608

GLP1 Agonists Once Weekly for the Treatment of Obesity in Patients With Bardet-Biedl Syndrome (BBS)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07602803
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 300
Start: 2023-01-01
Primary completion: 2026-04-01
Lead sponsor: The Queen Elizabeth Hospital
Conditions: Bardet-Biedl Syndrome
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Weight loss change (%) at the end of study date, compared to one at the time zero [From enrolment to the end of treatment at the end of study date up to 18 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.